Skip to main content
Loading
Toggle search
Toggle navigation
Keyword Search
Sign In
SNMMI.ORG
Home
Education
Resources
Centers of Excellence
2022 Fall Conference
Toggle
2022 Therapeutics Conference
Register
Agenda
Housing/National Harbor
Exhibiting Companies
Exhibits and Sponsorships
About SNMMI
Toggle
Our Mission
About Nuclear Medicine and Molecular Imaging
Career Center
Grants and Awards
Support SNMMI
Interviews and Educational Session Highlights
Setting Up a Theranostics Program
Session overview: Theranostics Regulatory
Considerations for Product Development
SNMMI Henry N. Wagner, Jr.,
Image of the Year - 2019
Session overview: PSMA Radioligand Therapy
(PRLT) of End-Stage Prostate Cancer
Patients Selected by PSMA PET/CT
Plenary overview: Theranostics
Looking Back and Moving Forward
Is a Cure for Cancer Within
Reach in the Coming Decades?
Patient-Focused Educational Vignettes
Learn More About Neuroendocrine Tumor (NET) Therapies
Current Imaging and Therapy of NETs
with Nuclear Medicine
Erik Mittra, MD, PhD
PRRT Patient Experience
Linda "Lindy" Gardner, BSN, RN
Future of PRRT and Molecular Imaging for NETs:
What is on the Horizon?
Richard Baum, MD, PhD
PRRT: Now, Later, Never?
George Fisher, MD, PhD
Learn More About Thyroid Cancer Therapies
What to Expect: Radioiodine Therapy
The Role of Radioiodine in
Thyroid Cancer Treatment
I-131 Therapy for Thyroid Cancer
Thyroid Imaging and Therapy
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##